Literature DB >> 16531324

Altered tumor biology and tumorigenesis in irradiated and chemical carcinogen-treated single and combined connexin32/p27Kip1-deficient mice.

Timothy J King1, Paul D Lampe.   

Abstract

Connexin32 knockout mice (Cx32-KO) exhibit increased chemical and radiation-induced liver and lung tumorigenesis. This increased tumor incidence is associated with altered tumor biology including enhanced tumor progression and an increased percent of MAPK-active tumors. Likewise, mice lacking the tumor suppressor/cell cycle regulator p27Kip1 exhibit increased tumorigenesis in a variety of tissues following chemical and radiation induction. Interestingly, in a double-deficient mouse model (DKO), additional loss of p27Kip1 in a Cx32-KO background results in attenuation of liver and lung tumorigenesis as well as MAPK activation profiles, suggesting pathway interaction. While these mouse strains exhibit altered liver and lung tumor susceptibility following both chemical (DEN) and radiation (X-ray) induction protocols, comparisons of the resulting tumor incidence, multiplicity, tumor progression, and MAPK activation in response to these two distinct carcinogens underscores the separate influence of each individual gene on both tumor formation and activation of specific oncogenic pathways. Furthermore, these studies demonstrate that different carcinogens interact disparately with Cx32/p27Kip1 genotypic backgrounds in situ resulting in varied tumorigenic response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16531324      PMCID: PMC1570041          DOI: 10.1080/15419060500514168

Source DB:  PubMed          Journal:  Cell Commun Adhes        ISSN: 1543-5180


  43 in total

Review 1.  Connexin disorders of the skin.

Authors:  G Richard
Journal:  Adv Dermatol       Date:  2001

Review 2.  Structural and functional diversity of connexin genes in the mouse and human genome.

Authors:  Klaus Willecke; Jürgen Eiberger; Joachim Degen; Dominik Eckardt; Alessandro Romualdi; Martin Güldenagel; Urban Deutsch; Goran Söhl
Journal:  Biol Chem       Date:  2002-05       Impact factor: 3.915

3.  Decrease in K-ras p21 and increase in Raf1 and activated Erk 1 and 2 in murine lung tumors initiated by N-nitrosodimethylamine and promoted by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  Gayatri Ramakrishna; Christine Perella; Lisa Birely; Bhalchandra A Diwan; Laura W Fornwald; Lucy M Anderson
Journal:  Toxicol Appl Pharmacol       Date:  2002-02-15       Impact factor: 4.219

Review 4.  Role of connexin32 and beta-catenin in tumor promotion in mouse liver.

Authors:  Michael Schwarz; Ines Wanke; Ulrich Wulbrand; Oliver Moennikes; Albrecht Buchmann
Journal:  Toxicol Pathol       Date:  2003 Jan-Feb       Impact factor: 1.902

5.  Impaired gap junction connexin43 in Sertoli cells of patients with secretory azoospermia: a marker of undifferentiated Sertoli cells.

Authors:  Norah Defamie; Isabelle Berthaut; Baharia Mograbi; Daniel Chevallier; Jean-Pierre Dadoune; Patrick Fénichel; Dominique Segretain; Georges Pointis
Journal:  Lab Invest       Date:  2003-03       Impact factor: 5.662

6.  Cannabinoids inhibit gap junctional intercellular communication and activate ERK in a rat liver epithelial cell line.

Authors:  Brad L Upham; Alisa M Rummel; Joseph M Carbone; James E Trosko; Yanli Ouyang; Robert B Crawford; Norbert E Kaminski
Journal:  Int J Cancer       Date:  2003-03-10       Impact factor: 7.396

7.  Inducible expression of the gap junction protein connexin43 decreases the neoplastic potential of HT-1080 human fibrosarcoma cells in vitro and in vivo.

Authors:  Timothy J King; Laurie H Fukushima; Yutaka Yasui; Paul D Lampe; John S Bertram
Journal:  Mol Carcinog       Date:  2002-09       Impact factor: 4.784

8.  Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice.

Authors:  Jeannette Philipp-Staheli; Kyung-Hoon Kim; Shannon R Payne; Kay E Gurley; Denny Liggitt; Gary Longton; Christopher J Kemp
Journal:  Cancer Cell       Date:  2002-05       Impact factor: 31.743

Review 9.  Connexins and cancer.

Authors:  Marc Mesnil
Journal:  Biol Cell       Date:  2002-11       Impact factor: 4.458

Review 10.  The Ras-Raf-MEK-ERK pathway in the treatment of cancer.

Authors:  R A Hilger; M E Scheulen; D Strumberg
Journal:  Onkologie       Date:  2002-12
View more
  3 in total

1.  Androgen-regulated formation and degradation of gap junctions in androgen-responsive human prostate cancer cells.

Authors:  Shalini Mitra; Lakshmanan Annamalai; Souvik Chakraborty; Kristen Johnson; Xiao-Hong Song; Surinder K Batra; Parmender P Mehta
Journal:  Mol Biol Cell       Date:  2006-10-18       Impact factor: 4.138

2.  Intercellular redistribution of cAMP underlies selective suppression of cancer cell growth by connexin26.

Authors:  Anjana Chandrasekhar; Edward A Kalmykov; Srikanth R Polusani; Sandra A Mathis; Shoshanna N Zucker; Bruce J Nicholson
Journal:  PLoS One       Date:  2013-12-03       Impact factor: 3.240

3.  Vitamin D3 regulates the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells.

Authors:  Linda Kelsey; Parul Katoch; Anuttoma Ray; Shalini Mitra; Souvik Chakraborty; Ming-Fong Lin; Parmender P Mehta
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.